Product image of Labentrol (Ciprofloxacin Hydrochloride Monohydrate) supplied by GNH India

Labentrol

Active Ingredient:
Ciprofloxacin Hydrochloride Monohydrate
Origin:
EU

Labentrol (Ciprofloxacin Hydrochloride Monohydrate)

Ciprofloxacin Hydrochloride Monohydrate, the active ingredient in Labentrol, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats bacterial infections of the urinary, respiratory, skin and gastrointestinal tracts in adults and children as appropriate.

GNH India supplies Labentrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sja Pharm Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Labentrol (ciprofloxacin) is a fluoroquinolone antibiotic that targets a broad range of bacterial pathogens in several organ systems.

  • Urinary tract infections: eradicates common uropathogens and resolves symptoms.
  • Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible bacteria.
  • Skin and soft tissue infections: clears bacterial cellulitis, abscesses and wound infections.
  • Gastrointestinal infections: manages bacterial gastroenteritis and travel‑related diarrhoea.

How It Works

  • Ciprofloxacin Hydrochloride Monohydrate inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By blocking these targets, the drug prevents bacterial DNA synthesis and transcription, leading to bactericidal activity against susceptible Gram‑negative and Gram‑positive organisms.

Side Effects

Ciprofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: transient gastrointestinal upset.
  • Diarrhoea: may be mild to moderate.
  • Headache: occasional tension‑type headache.
  • Dizziness: transient light‑headedness.
  • Rash: mild skin erythema.
  • Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles tendon, often linked to activity.
  • Peripheral neuropathy: sensory disturbances that may be irreversible.
  • Clostridioides difficile‑associated diarrhoea: severe colitis.
  • Severe allergic reactions: anaphylaxis or angioedema.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.

Precautions & Warnings

Before prescribing Labentrol, clinicians should consider several safety factors.

  • Renal function: adjust use in patients with severe renal impairment.
  • Age considerations: use caution in pediatric and elderly patients.
  • Photosensitivity: advise patients to avoid excessive sunlight exposure.
  • Drug resistance: limit use to confirmed bacterial infections to reduce resistance development.
  • Pregnancy and lactation: safety not established; weigh benefits against potential risks.
  • Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Ciprofloxacin interacts with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce ciprofloxacin absorption.
  • Warfarin: may increase anticoagulant effect; monitor INR closely.
  • Theophylline: increased plasma levels can lead to toxicity.

Moderate Interactions (Monitor Closely)

  • Nonsteroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation.
  • Corticosteroids: heightened risk of tendon rupture.
  • Diabetes medications (e.g., insulin, sulfonylureas): may affect glucose control.

Frequently Asked Questions

Labentrol contains ciprofloxacin, a broad‑spectrum fluoroquinolone antibiotic indicated for the treatment of urinary tract infections, respiratory tract infections, skin and soft‑tissue infections, and certain gastrointestinal infections caused by susceptible bacteria.

Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This blockade prevents bacterial DNA synthesis, leading to rapid bactericidal activity against a wide range of Gram‑negative and Gram‑positive organisms.

The dose of Labentrol is determined by the prescribing clinician based on the type and severity of infection, patient age, renal function and other clinical factors. Only a qualified healthcare professional should set the dosing regimen.

Safety data for ciprofloxacin in pregnancy and lactation are limited. It should be used only when the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Labentrol, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Labentrol (ciprofloxacin) shares the class‑wide mechanism of DNA‑gyrase inhibition but differs in spectrum and pharmacokinetics from alternatives such as levofloxacin or moxifloxacin. Ciprofloxacin generally offers strong activity against Gram‑negative pathogens and is often chosen for urinary and gastrointestinal infections.

Store Labentrol at ambient temperature below 25 °C, in the original packaging, protected from moisture and direct sunlight. Do not expose the tablets to excessive heat or humidity to maintain potency.

Labentrol is taken orally as a tablet with a full glass of water. It may be taken with or without food, but patients should follow any specific instructions from their prescriber regarding timing relative to meals.

Serious adverse events include tendon rupture (especially Achilles), peripheral neuropathy, Clostridioides difficile‑associated colitis, QT interval prolongation, severe allergic reactions such as anaphylaxis, and hepatic dysfunction. Patients should seek immediate medical attention if any of these occur.

Labentrol should be avoided in individuals with a known hypersensitivity to ciprofloxacin or other fluoroquinolones, those with a history of tendon disorders, patients receiving concomitant corticosteroids, and anyone for whom a safer alternative is available based on clinical judgment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ciprofloxacin Hydrochloride Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT